Search

everythinglearnresearchcommunity

for

Search:↓

Vitiligo causes white skin patches and is linked to autoimmune issues.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Stem cell therapy may help treat tough hair loss cases.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Toxic shock syndrome is caused by a complex interaction of bacterial toxins and the immune system, and understanding this can help improve diagnosis and treatment.

Bone-marrow and epidermal stem cells help heal wounds differently, with bone-marrow cells aiding in blood vessel formation and epidermal cells in hair growth.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Cell-based therapies show promise for treating Limbal Stem Cell Deficiency but need more research.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Consider benefits and risks of new alopecia treatments for safety.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.